COVID-19 Updates
For the most up-to-date information on COVID-19, please visit the Department of Health Services website.
See the guidelines for public meetings during this public health emergency period here.
For the most up-to-date information on COVID-19, please visit the Department of Health Services website.
See the guidelines for public meetings during this public health emergency period here.
DRUG UTILIZATION REVIEW (DUR) BOARD MEETING
Wednesday, March 6, 2023
1:00PM to 4:00PM
Virtual Meeting
To register for this meeting, please right click on the link below. You may need to copy and paste this link in your browser.
https://dhswi.zoomgov.com/w/1604755990?tk=xi--P6J0-wOQ3dfbTDTkbSnzFB5AL5T32cAsOSVYYuc.DQYAAAAAX6aiFhpmYWtlVEtybnM0cmdSS0NCcm5Sa2RaXzlOQQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
To register for this meeting by phone, please call:
1+ (646) 828-7666 (US Toll) or 1+ (669) 254-5252
Meeting ID: 160 475 5990
The DUR Board is a federally mandated Board which meets on a quarterly basis to review and make recommendations to the Department on predetermined standards for retrospective and prospective drug utilization.
1:00-1:05 Welcome and Introductions Kim Wohler
1:05-1:10 Review of the Agenda and Board Materials Kim Wohler
1:10-1:15 Approval of Minutes: December 6, 2023 Kim Wohler
1:15-1:45 Updates Lynn Radmer, RPh
• Quarterly Reports
• Naloxone Breakout Analysis
1:45-2:00 Sickle Cell Medication Underutilization Lynn Radmer, RPh
2:00-2:15 Long-Term Use of High-Dose Benzodiazepine Lynn Radmer, RPh
Impact Analysis
2:15-2:30 Buprenorphine & Benzodiazepine Intervention Lynn Radmer, RPh
Burt Copeland, MD
2:30-2:45 Break
2:45-3:15 Annual Lock-In Report Katie Counts, Pharm D
3:15-3:45 Mood Stabilizers in Children Burt Copeland, MD
3:45-4:00 Dental Intervention Lynn Radmer, RPh
4:00 Adjournment Kim Wohler
The purpose of this meeting is to conduct the governmental business outlined in the above agenda. The Drug Utilization Review Board is a federally mandated Board which meets on a quarterly basis to review and make recommendations to the Department on predetermined standards for retrospective and prospective drug utilization.
DHS is an equal opportunity employer and service provider. If you need accommodations because of a disability, if you need an interpreter or translator, or if you need this material in another language or in alternate format, you may request assistance to participate by contacting Tiffaney Reilly at 608-266-9438 or tiffaney.reilly@dhs.wisconsin.gov
Reasonable accommodations, including the provision of informational material in an alternative format, will be provided for qualified individuals with disabilities upon request. This agency, to the maximum extent possible, holds all meetings in facilities that are physically accessible to persons with disabilities. For questions about accessibility, contact the meeting's sponsoring division.